Learn more

NOVAREMED LTD

Overview
  • Total Patents
    45
  • GoodIP Patent Rank
    160,312
  • Filing trend
    ⇩ 100.0%
About

NOVAREMED LTD has a total of 45 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are PHARMACOFORE INC, PHILERA NEW ZEALAND LTD and CENTAUR PHARMACEUTICALS INC.

Patent filings per year

Chart showing NOVAREMED LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kaplan Eliahu 38
#2 Gil-Ad Irit 6
#3 Bittner Shmuel 2
#4 Kaplan Eliahu E 2
#5 Harlev Eliakim 2
#6 Eliahu Kaplan 2
#7 Kaplan Eliyahu 1
#8 Hett Robert 1
#9 Kaplan Eli 1

Latest patents

Publication Filing date Title
WO2020152226A1 Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity
WO2015173813A1 Pharmaceutical composition comprising stereoisomers of n-(1-(4-hydroxyphenyl)-3-(2-hydroxypropoxy)propan-2-yl)-3-phenylpropanamide for the prevention and treatment of type ii diabetes
US2014350099A1 Method of Treating or Preventing Pain
AU2012348529A1 Isolated stereoisomeric forms of (S) 2-N (3-O-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide
GB201116335D0 A method of treating or preventing affective disorders
WO2011030205A1 N-substituted benzenepropanamide or benzenepropenamide for use in the treatment of pain and inflammation
AU2009220931A1 N-substitutedbenzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation
AU2007246779A1 Compounds for the treatment of cell proliferative disorders
US2005239898A1 Compounds for the treatment of AIDS and other viral diseases
AU2003274605A1 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection